Zhu X H, Li X M, Zhang W L, Liao M M, Li Y, Wang F F, Shang B, Peng L G, Su Y J, You Z J, Shi J Y, Zhong W L, Liang X R, Liang C J, Liang L, Liao W T, Ding Y Q
Department of Pathology, Nanfang Hospital and Basic Medical College, Southern Medical University, Guangzhou 510515, China.
Department of Pathology, Shenzhen Bao'an People's Hospital(Group), Shenzhen 518101, China.
Zhonghua Bing Li Xue Za Zhi. 2021 Apr 8;50(4):333-338. doi: 10.3760/cma.j.cn112151-20201013-00780.
To explore the application value of artificial intelligence-assisted diagnosis system for TBS report in cervical cancer screening. A total of 16 317 clinical samples and related data of cervical liquid-based thin-layer cell smears, which were obtained from July 2020 to September 2020, were collected from Southern Hospital, Guangzhou Huayin Medical Inspection Center, Shenzhen Bao'an People's Hospital(Group) and Changsha Yuan'an Biotechnology Co., Ltd. The TBS report artificial intelligence-assisted diagnosis system of cervical liquid-based thin-layer cytology jointly developed by Southern Medical University and Guangzhou F. Q. PATHOTECH Co., Ltd. based on deep learning convolution neural network was used to diagnose all clinical samples. The sensitivity,specificity and accuracy of both artificial intelligence-assisted diagnosis system and cytologists using artificial intelligence-assisted diagnosis system were analyzed based on the evaluation standard(2014 TBS). The time spent by the two methods was also compared. The sensitivity of artificial intelligence-assisted diagnosis system in predicting cervical intraepithelial lesions and other lesions (including endometrial cells detected in women over 45 years old and infectious lesions) under different production methods, different cytoplasmic staining and different scanning instruments was 92.90% and 83.55% respectively, and the specificity of negative samples was 87.02%, while that of cytologists using artificial intelligence-assisted diagnosis system was 99.34%, 97.79% and 99.10%, respectively. Moreover, cytologists using artificial intelligence-assisted diagnosis system could save about 6 times of reading time than manual. Artificial intelligence-assisted diagnosis system for TBS report of cervical liquid-based thin-layer cytology has the advantages of high sensitivity, high specificity and strong generalization. Cytologists can significantly improve the accuracy and work efficiency of reading smears by using artificial intelligence-assisted diagnosis system.
探讨人工智能辅助诊断系统在宫颈癌筛查TBS报告中的应用价值。收集2020年7月至2020年9月期间,来自南方医院、广州华银医学检验中心、深圳市宝安区人民医院(集团)和长沙源安生物科技有限公司的16317份宫颈液基薄层细胞涂片临床样本及相关数据。采用南方医科大学与广州孚合新生物科技有限公司基于深度学习卷积神经网络联合开发的宫颈液基薄层细胞学TBS报告人工智能辅助诊断系统对所有临床样本进行诊断。依据(2014 TBS)评估标准,分析人工智能辅助诊断系统及使用该系统的细胞病理学家诊断的灵敏度、特异度和准确度。同时比较两种方法的用时。人工智能辅助诊断系统在不同制片方法、不同细胞质染色及不同扫描仪器下预测宫颈上皮内病变及其他病变(包括45岁以上女性检出的子宫内膜细胞及感染性病变)的灵敏度分别为92.90%和83.55%,阴性样本特异度为87.02%,而使用人工智能辅助诊断系统的细胞病理学家的灵敏度分别为99.34%、97.79%和99.10%。此外,使用人工智能辅助诊断系统的细胞病理学家的阅片时间比人工阅片节省约6倍。宫颈液基薄层细胞学TBS报告人工智能辅助诊断系统具有灵敏度高、特异度高、泛化性强的优点。细胞病理学家使用人工智能辅助诊断系统可显著提高涂片阅片的准确性和工作效率。